Literature DB >> 1517917

Familial hypotonia of childhood caused by isolated 3-methylcrotonyl-coenzyme A carboxylase deficiency.

O N Elpeleg1, S Havkin, V Barash, C Jakobs, B Glick, R S Shalev.   

Abstract

Hypotonia was the initial symptom in four siblings from a nonconsanguineous Tunisian-Jewish family. Plasma carnitine was severely deficient, and urinary organic acid analysis revealed increased excretion of 3-hydroxyisovaleric acid and 3-methylcrotonylglycine. 3-Methylcrotonyl-coenzyme A carboxylase activity was reduced in skin fibroblasts; pyruvate carboxylase and serum biotinidase activities were normal. We conclude that 3-methylcrotonyl-coenzyme A carboxylase deficiency should be added to the list of metabolic causes of familial hypotonia of childhood.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1517917     DOI: 10.1016/s0022-3476(05)81796-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  10 in total

1.  Primary and maternal 3-methylcrotonyl-CoA carboxylase deficiency: insights from the Israel newborn screening program.

Authors:  Jonathan Rips; Shlomo Almashanu; Hanna Mandel; Sagi Josephsberg; Tally Lerman-Sagie; Ayelet Zerem; Ben Podeh; Yair Anikster; Avraham Shaag; Anthony Luder; Orna Staretz Chacham; Ronen Spiegel
Journal:  J Inherit Metab Dis       Date:  2015-11-13       Impact factor: 4.982

Review 2.  The consequences of extended newborn screening programmes: do we know who needs treatment?

Authors:  B Wilcken
Journal:  J Inherit Metab Dis       Date:  2008-02-22       Impact factor: 4.982

3.  Benign clinical presentation of 3-methylcrotonylglycinuria.

Authors:  M A Pearson; K A Aleck; R A Heidenreich
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

4.  Leukodystrophy and CSF purine abnormalities associated with isolated 3-methylcrotonyl-CoA carboxylase deficiency.

Authors:  Raquel Dodelson de Kremer; Alexandra Latini; Terttu Suormala; E Regula Baumgartner; Laura Laróvere; Gabriel Civallero; Norberto Guelbert; Ana Paschini-Capra; Catalina Depetris-Boldini; Carlos Quiroga Mayor
Journal:  Metab Brain Dis       Date:  2002-03       Impact factor: 3.584

5.  Glycine and L-carnitine therapy in 3-methylcrotonyl-CoA carboxylase deficiency.

Authors:  S L Rutledge; G T Berry; C A Stanley; J L van Hove; D Millington
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

6.  Isolated biotin-resistant 3-methylcrotonyl-CoA carboxylase deficiency: long-term outcome in a case with neonatal onset.

Authors:  W Lehnert; H Niederhoff; T Suormala; E R Baumgartner
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

7.  Evaluation of 3-methylcrotonyl-CoA carboxylase deficiency detected by tandem mass spectrometry newborn screening.

Authors:  D D Koeberl; D S Millington; W E Smith; S D Weavil; J Muenzer; S E McCandless; P S Kishnani; M T McDonald; S Chaing; A Boney; E Moore; D M Frazier
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

8.  3-Hydroxyisovalerylcarnitine in 3-methylcrotonyl-CoA carboxylase deficiency.

Authors:  J L van Hove; S L Rutledge; M A Nada; S G Kahler; D S Millington
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

9.  Outcomes of cases with 3-methylcrotonyl-CoA carboxylase (3-MCC) deficiency - Report from the Inborn Errors of Metabolism Information System.

Authors:  RaeLynn Forsyth; Catherine Walsh Vockley; Mathew J Edick; Cynthia A Cameron; Sally J Hiner; Susan A Berry; Jerry Vockley; Georgianne L Arnold
Journal:  Mol Genet Metab       Date:  2016-02-15       Impact factor: 4.797

10.  Expanded Newborn Screening for Inborn Errors of Metabolism by Tandem Mass Spectrometry in Suzhou, China: Disease Spectrum, Prevalence, Genetic Characteristics in a Chinese Population.

Authors:  Ting Wang; Jun Ma; Qin Zhang; Ang Gao; Qi Wang; Hong Li; Jingjing Xiang; Benjing Wang
Journal:  Front Genet       Date:  2019-10-29       Impact factor: 4.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.